(4S,4'S)-2,2'-(((3,3-Dimethylbut-1-yn-1-yl)phosphanediyl)bis(2,1-phenylene))bis(4-isopropyl-4,5-dihydrooxazole)

Catalog No. :
ACGCOU350
CAS No. :
2649382-76-1
Molecular Formula :
C30H37N2O2P
Molecular Weight :
488.61

IUPAC Name:(4S,4'S)-2,2'-(((3,3-dimethylbut-1-yn-1-yl)phosphanediyl)bis(2,1-phenylene))bis(4-isopropyl-4,5-dihydrooxazole)

(4S,4'S)-2,2'-(((3,3-Dimethylbut-1-yn-1-yl)phosphanediyl)bis(2,1-phenylene))bis(4-isopropyl-4,5-dihydrooxazole) structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(4S,4'S)-2,2'-(((3,3-Dimethylbut-1-yn-1-yl)phosphanediyl)bis(2,1-phenylene))bis(4-isopropyl-4,5-dihydrooxazole)
IUPAC Name(4S,4'S)-2,2'-(((3,3-dimethylbut-1-yn-1-yl)phosphanediyl)bis(2,1-phenylene))bis(4-isopropyl-4,5-dihydrooxazole)
Molecular FormulaC30H37N2O2P
Molecular Weight488.61
SMILESCC(C)(C)C#CP(C1=CC=CC=C1C2=N[C@H](CO2)C(C)C)C3=C(C4=N[C@H](CO4)C(C)C)C=CC=C3
InChI KeyLKBDPVAEMPLQLY-JWQCQUIFSA-N
Synonym(4S,4'S)-2,2'-(((3,3-Dimethylbut-1-yn-1-yl)phosphinediyl)bis(2,1-phenylene))bis(4-isopropyl-4,5-dihydrooxazole);Oxazole, 2,2′-[[(3,3-dimethyl-1-butyn-1-yl)phosphinidene]di-2,1-phenylene]bis[4,5-dihydro-4-(1-methylethyl)-, (4S,4′S)-
CAS No.2649382-76-1

Synthetic Route by SureRoute

1. ACGCOU350 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACGCOU350 route product structure diagram
    ACGCOU3502649382-76-1
Inquiry

2. ACGCOU350 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACGCOU350 route product structure diagram
    ACGCOU3502649382-76-1
Inquiry

Comments (0)